Tandem Diabetes Care TNDM
NASDAQ TNDM
$16.35 -0.17 (-1.03%)
At close: Oct 21, 2026 · 4:00 PM EDT

Tandem Diabetes Care (TNDM) EV to EBITDA (2020 - 2022)

Updated

Tandem Diabetes Care's (TNDM) EV to EBITDA stood at 453.35 in Q2 2022, up 169.3% from 168.32 a year earlier and up 63.6% from the prior quarter.

Analysis

Tandem Diabetes Care (TNDM) EV to EBITDA (2020 - 2022) Analysis & Trends

On a TTM basis, Tandem Diabetes Care's EV to EBITDA came in at 187.78 as of Jun 30, 2022, up 51.1% year-over-year; for FY2021, it came in at 246.16, down 88.8% from FY2020.

  • Across earlier years, EV to EBITDA came in at 2196.98 in FY2020.
  • The Q2 2022 figure is the highest quarterly EV to EBITDA since Q4 2020.
  • Per Business Quant, the preceding three quarters came in at 277.11 (Q1 2022), 246.16 (Q4 2021) and 164.89 (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Tandem Diabetes Care 1.13 Bn -508.32 Mn 144.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 361.91
Mar 31, 2022 258.79
Dec 31, 2021 235.04
Sep 30, 2021 146.99
Jun 30, 2021 134.00
Mar 31, 2021 200.27
Dec 31, 2020 435.21
API Access

Tandem Diabetes Care EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TNDM&period=max&api_key=YOUR_API_KEY